NANOG and cancer: Furthermore, the qRT‐PCR results also showed a significantly decreased mRNA expression of Nanog, Klf4, survivin, and β‐catenin in napabucasin treatment with PC‐3 stemness‐high cancer cells (Fig. 4B, P < 0.05).